Immune Activation in Chronic Heart Failure
Open Access
- 1 June 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (11) , 3-8
- https://doi.org/10.1016/j.amjcard.2005.03.006
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Biologic Effects and Basic Science of a Novel Immune-Modulation TherapyThe American Journal of Cardiology, 2005
- Broad Modulation of Tissue Responses (Immune Activation) by Celacade May Favorably Influence Pathologic Processes Associated with Heart Failure ProgressionThe American Journal of Cardiology, 2005
- Inflammatory Mediators and the Failing HeartCirculation Research, 2002
- Intravenous immunoglobulin consensus statement☆☆☆Journal of Allergy and Clinical Immunology, 2001
- Cardiac Autoantibodies to Myosin and Other Heart-specific Autoantigens in Myocarditis and Dilated CardiomyopathyAutoimmunity, 2001
- A Peptide Fragment of β Cardiac Myosin Heavy Chain (β-CMHC) Can Provoke Autoimmune Myocarditis as well as the Corresponding a Cardiac Myosin Heavy Chain (α-CMHC) FragmentAutoimmunity, 2001
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureNew England Journal of Medicine, 1998
- Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)Journal of the American College of Cardiology, 1996
- Anti-β-receptor antibodies in familial cardiomyopathy: Correlation with HLA-DR and HLA-DQ gene polymorphismsAmerican Heart Journal, 1994
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991